Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc.
Your view on SLNO
Overview
What the company does, where it operates, and who runs it.
About Soleno Therapeutics, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Anish Bhatnagar
- Headquarters
- 203 Redwood Shores Parkway, Redwood City, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Anish Bhatnagar
- Headquarters
- 203 Redwood Shores Parkway, Redwood City, CA, US
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.